Wolf Z, Mani H, Lindhoff-Last E
Medizinische Klinik III, Schwerpunkt Angiologie und Hämostaseologie, Klinikum der Johann Wolfgang Goethe-Universität, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Deutschland.
Internist (Berl). 2010 Sep;51(9):1095-6, 1098-100, 1102-8. doi: 10.1007/s00108-009-2569-6.
Numerous laboratory tests are in use to detect congenital or acquired platelet function disorders. Platelet aggregometry, using ADP, collagen, arachidonic acid or ristocetin as inductor is the standard test system for diagnosis. It is also used to detect platelet non-response to antiplatelet therapy. Studies have demonstrated that laboratory assessment of platelet non response to aspirin or clopidogrel is associated with adverse outcomes, and they indicate the importance of adjusting antiplatelet therapy in patients with a low degree of platelet inhibition. Nevertheless, a standardized method for identifying these patients is still missing.
目前有许多实验室检测方法可用于检测先天性或获得性血小板功能障碍。以二磷酸腺苷(ADP)、胶原蛋白、花生四烯酸或瑞斯托霉素作为诱导剂的血小板聚集试验是诊断的标准检测系统。它还用于检测血小板对抗血小板治疗无反应的情况。研究表明,实验室评估血小板对阿司匹林或氯吡格雷无反应与不良后果相关,这表明在血小板抑制程度较低的患者中调整抗血小板治疗的重要性。然而,目前仍缺乏一种识别这些患者的标准化方法。